Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 3Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Neoplasms 1Depression 1Brain Neoplasms 1

Interventions

Therapeutics 25Psychiatric Rehabilitation 16Cognitive Behavioral Therapy 10Early Intervention, Educational 9Methods 7Yoga 6Mindfulness-Based Cognitive Therapy 6Esketamine 5Educational Status 5Surveys and Questionnaires 4Saline Solution 4Psychosocial Intervention 4Mindfulness 4Interviews as Topic 4Counseling 4Control Groups 4Caregivers 4Behavior Therapy 4Acupuncture Therapy 4Palliative Care 3Meditation 3Hypnosis 3Exercise Therapy 3Transcranial Magnetic Stimulation 2Transcranial Direct Current Stimulation 2Standard of Care 2Self-Help Groups 2Psychotherapy 2Mindfulness-Based Stress Reduction 2Massage 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Depression × Vorinostat × Clear all
NCT01342757 2018-01-29

Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma

National Cancer Institute (NCI)

Phase NA Completed
12 enrolled 8 charts
CNS

Brain Neoplasms, Depression, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡